OncoSil Medical Health Care
Cancer Health Care

$0.012 (0%)

High $0.01	Low $0.01	Trades 21	Turnover $70,215	Volume 5,851,219
30 June 2023 at 4:10pm

Market Cap (2-Oct) $30,096,984 (1,393rd)	Close (30-Jun) $0.012 0 (0%)	Volume (30-Jun) 5,851,219	Shortsold (28-Sep) 66 (0.00%) (648th)
52w High $1.81	52w Low $0.370	P/E 4.51	EPS -0.45

Short Interest

ASIC data, 28 Sep 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

648th

of 704 shorted ASX stocks

Peak Short

0.69%

Dec 2024

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	OSL OSL Ann: Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer
	1 (current) 2 3
	OSL OSL Ann: Notification of cessation of securities - OSL
	OSL OSL Ann: Ethics Committee Approves PANCOSIL Clinical Trial
	OSL OSL Ann: Change of CFO, Company Secretary and Registered Office
	OSL OSL Ann: Resignation of Chief Financial Officer
	OSL OSL Ann: Mr Otto Buttula to Retire from the Board
	OSL OSL Ann: First patient treatment in Italy
	OSL OSL Ann: Becoming a substantial holder
	OSL OSL Ann: Notification of cessation of securities - OSL
	OSL OSL Ann: Change of Director's Interest Notice - Brian Leedman
	OSL OSL Ann: Change of Director's Interest Notice - Nigel Lange
	OSL OSL Ann: Top 20 Holdings and Distribution Schedule of OSLO Options
	OSL OSL Ann: Application for quotation of securities - OSL
	OSL OSL Ann: Entitlement Offer Results and Shortfall Notification
	OSL OSL Ann: First patient enrolled in the TRIPP-FFX Clinical Study
	OSL OSL Ann: OncoSil to streamline operating structure
	OSL OSL Ann: First year anniversary of the OSPREY post-marketing registry
	OSL OSL Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	OSL OSL Ann: Late Lodgement of Change in Director's Interest Notice
	OSL OSL Ann: Update - Proposed issue of securities - OSL
	OSL OSL Ann: Oral presentation at The Mayo Clinic IMPACT Course
	OSL OSL Ann: Further commercial milestones achieved in Spain
	OSL OSL Ann: Extension of Closing Date of Entitlement Offer
	OSL OSL Ann: Additional Binding Commitment Received for Entitlement Offer
	OSL OSL Ann: Letter to Ineligible Shareholders
	OSL OSL Ann: Entitlement Offer - Despatch of Documents
	OSL OSL Ann: Non-renounceable Rights Issue Offer Prospectus
	OSL OSL Ann: Update - Proposed issue of securities - OSL
	OSL OSL Ann: Commitment received for Offer and updated Timetable
	OSL OSL Ann: Proposed issue of securities - OSL
	OSL OSL Ann: Entitlement Offer Presentation
	OSL OSL Ann: Entitlement Offer to raise up to $9.9 million
	OSL OSL Ann: Final Director's Interest Notice
	OSL OSL Ann: Change of Director's Interest Notice
	OSL OSL Ann: Cancellation of Unlisted Options and Loan Funded Shares
	OSL OSL Ann: Half-Yearly Report Results
	OSL OSL Ann: Half Yearly Report and Accounts
	OSL OSL Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	OSL OSL Ann: Two key treatment centres treat first patients with OncoSil
	OSL OSL Ann: OncoSil achieves milestone of 10 patients treated in Spain
	OSL OSL Ann: Distribution agreement signed for selected Chinese markets
	OSL OSL Ann: Change of Director's Interest Notice
	OSL OSL Ann: Application for quotation of securities - OSL
	OSL OSL Ann: Cleansing Notice
	OSL OSL Ann: OncoSil to present at TechKnow Invest 2022
	OSL OSL Ann: Change of Director's Interest Notice
	OSL OSL Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	OSL OSL Ann: Change of Registry Address
	OSL OSL Ann: OncoSil to present at AusBioInvest 2022
	OSL OSL Ann: Change of Director's Interest Notice - Nigel Lange

Similar Companies

AnteoTech

ADO

BPH Energy

BPH

Cryosite

CTE

Genetic Signatures

GSS

Genetic Technologies

GTG

Memphasys

MEM

Palla Pharma

PAL

Proteomics International Laboratories

PIQ

End of Day Prices

Date	Close	Volume	Change
02-Oct	$0.79	52,731	-0.03 (3.66%)
01-Oct	$0.82	18,627	-0.05 (5.20%)
30-Sep	$0.87	6,000	+0.02 (1.76%)
29-Sep	$0.85	58,059	-0.01 (1.16%)
28-Sep	$0.86	54,099	+0.01 (1.18%)
25-Sep	$0.85	21,245	+0.03 (3.03%)
24-Sep	$0.83	76,031	-0.06 (6.78%)
23-Sep	$0.89	170,701	-0.05 (5.85%)
22-Sep	$0.94	14,465	+0.01 (1.62%)
21-Sep	$0.93	107,642	-0.09 (8.87%)
18-Sep	$1.02	65,964	+0.04 (4.64%)
17-Sep	$0.97	24,737	-0.01 (0.51%)
16-Sep	$0.98	30,436	-0.04 (3.94%)
15-Sep	$1.02	16,425	+0.03 (3.57%)
14-Sep	$0.98	7,040	+0.01 (0.51%)
7 up, 8 down, and 0 flat days

OncoSil Medical Health Care
Cancer Health Care

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

OncoSil Medical Health Care Cancer Health Care

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

OncoSil Medical Health Care
Cancer Health Care